Syros Pharmaceuticals, Inc. (SYRS)
NASDAQ: SYRS · Real-Time Price · USD
2.430
+0.165 (7.28%)
Nov 4, 2024, 4:00 PM EST - Market closed
Syros Pharmaceuticals Employees
Syros Pharmaceuticals had 68 employees as of December 31, 2023. The number of employees decreased by 49 or -41.88% compared to the previous year.
Employees
68
Change (1Y)
-49
Growth (1Y)
-41.88%
Revenue / Employee
$5,676
Profits / Employee
-$1,438,456
Market Cap
65.15M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
P3 Health Partners | 400 |
Enzo Biochem | 190 |
Omega Therapeutics | 94 |
Shattuck Labs | 75 |
Kronos Bio | 63 |
ESSA Pharma | 50 |
Gain Therapeutics | 32 |
Serina Therapeutics | 11 |
SYRS News
- 18 hours ago - The Schall Law Firm Invites Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Related Infractions - Accesswire
- 1 day ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm - Accesswire
- 2 days ago - The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations - Accesswire
- 4 days ago - Syros Pharmaceuticals, Inc (SYRS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 days ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm - Accesswire
- 4 days ago - Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update - Business Wire
- 5 days ago - The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations - Accesswire
- 6 days ago - Syros Pharmaceuticals Inc Is Being Investigated For Securities Fraud And Shareholders Are Encouraged To Contact The Schall Law Firm - Accesswire